Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 299 items for :

  • hyperthyroidism x
Clear All
Georgios Kostopoulos Department of Endocrinology and Metabolism, Ippokratio General Hospital of Thessaloniki, Greece

Search for other papers by Georgios Kostopoulos in
Google Scholar
PubMed Close
and
Grigoris Effraimidis Department of Endocrinology and Metabolic Diseases, Larissa University Hospital, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece

Search for other papers by Grigoris Effraimidis in
Google Scholar
PubMed Close

infarction, heart failure, and stroke are other common risk factors for AF ( 3 ). Today, the increased knowledge of the genetic causes of AF has revealed around 140 genetic loci associated with AF ( 4 ). Hyperthyroidism is also a common condition with an

Article Type:
Review Article
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-23-0254
Volume/Issue:
Volume 13: Issue 2
Open access
Thea Riis Department of Endocrinology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Thea Riis in
Google Scholar
PubMed Close
,
Steen Joop Bonnema Department of Endocrinology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed Close
,
Thomas Heiberg Brix Department of Endocrinology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Thomas Heiberg Brix in
Google Scholar
PubMed Close
, and
Lars Folkestad Department of Endocrinology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Lars Folkestad in
Google Scholar
PubMed Close

, 12 ). It is unsettled whether these pathophysiological observations can translate into an increased risk of non-thyroid cancer in patients with hyperthyroidism ( 13 ). Results from some ( 14 , 15 , 16 , 17 , 18 ), but not all ( 19 , 20 , 21

Article Type:
Research Article
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-23-0181
Volume/Issue:
Volume 13: Issue 2
Open access
J Karmisholt Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Department of Clinical Institute, Aalborg University, Aalborg, Denmark

Search for other papers by J Karmisholt in
Google Scholar
PubMed Close
,
S L Andersen Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by S L Andersen in
Google Scholar
PubMed Close
,
I Bulow-Pedersen Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Department of Clinical Institute, Aalborg University, Aalborg, Denmark

Search for other papers by I Bulow-Pedersen in
Google Scholar
PubMed Close
,
A Krejbjerg Department of Oncology, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by A Krejbjerg in
Google Scholar
PubMed Close
,
B Nygaard Department of Endocrinology and Internal Medicine, Herlev University Hospital, Copenhagen, Denmark

Search for other papers by B Nygaard in
Google Scholar
PubMed Close
, and
A Carlé Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Department of Clinical Institute, Aalborg University, Aalborg, Denmark

Search for other papers by A Carlé in
Google Scholar
PubMed Close

Introduction Graves’ hyperthyroidism (GH) is an autoimmune disease mainly affecting the thyroid gland ( 1 , 2 ). The disease is usually transient with remission occurring within a period of 1–2 years after treatment with anti-thyroid drugs

Article Type:
Research Article
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-22-0031
Volume/Issue:
Volume 11: Issue 3
Open access
Earn H. Gan Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom

Search for other papers by Earn H. Gan in
Google Scholar
PubMed Close
,
Anna L. Mitchell Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom

Search for other papers by Anna L. Mitchell in
Google Scholar
PubMed Close
,
Ruth Plummer Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom

Search for other papers by Ruth Plummer in
Google Scholar
PubMed Close
,
Simon Pearce Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom

Search for other papers by Simon Pearce in
Google Scholar
PubMed Close
, and
Petros Perros Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom

Search for other papers by Petros Perros in
Google Scholar
PubMed Close

by thyroid disorders. This report describes a case of Graves hyperthyroidism after 8 years of tremelimumab therapy. We speculate a causal relationship between tremelimumab therapy and the development of Graves disease, and highlight the importance

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000464285
Volume/Issue:
Volume 6: Issue 3
Free access
Clotilde Saïe Thyroid and Endocrine Tumors Unit, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France

Search for other papers by Clotilde Saïe in
Google Scholar
PubMed Close
,
Cécile Ghander Thyroid and Endocrine Tumors Unit, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France

Search for other papers by Cécile Ghander in
Google Scholar
PubMed Close
,
Samir Saheb Apheresis Unit, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France

Search for other papers by Samir Saheb in
Google Scholar
PubMed Close
,
Christel Jublanc Department of Endocrinology, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France

Search for other papers by Christel Jublanc in
Google Scholar
PubMed Close
,
Denis Lemesle Department of Anaesthesia, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France

Search for other papers by Denis Lemesle in
Google Scholar
PubMed Close
,
Charlotte Lussey-Lepoutre Nuclear Medicine Department, Pitié-Salpêtrière Hospital APHP, Sorbonne Université, Inserm U970, Paris, France

Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed Close
,
Laurence Leenhardt Thyroid and Endocrine Tumors Unit, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France

Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed Close
,
Fabrice Menegaux Department of Surgery, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France

Search for other papers by Fabrice Menegaux in
Google Scholar
PubMed Close
,
Christophe Tresallet Department of Surgery, Avicennes Hospital, Paris, France

Search for other papers by Christophe Tresallet in
Google Scholar
PubMed Close
, and
Camille Buffet Thyroid and Endocrine Tumors Unit, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France

Search for other papers by Camille Buffet in
Google Scholar
PubMed Close

) is an effective blood purification procedure used to treat various disorders such as autoimmune diseases and familial hypercholesterolemia [ 2 ]. In hyperthyroidism, TPE has been used since 1970 [ 3 ] and is mainly considered for use in clinical

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000507019
Volume/Issue:
Volume 10: Issue 1
Free access
Stine Linding Andersen Department of Endocrinology, Aalborg University Hospital, Aarhus, Denmark
Department of Clinical Medicine, Aalborg University, Aalborg, Aarhus, Denmark

Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed Close
,
Jørn Olsen Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark

Search for other papers by Jørn Olsen in
Google Scholar
PubMed Close
,
Chun Sen Wu Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark

Search for other papers by Chun Sen Wu in
Google Scholar
PubMed Close
, and
Peter Laurberg Department of Endocrinology, Aalborg University Hospital, Aarhus, Denmark
Department of Clinical Medicine, Aalborg University, Aalborg, Aarhus, Denmark

Search for other papers by Peter Laurberg in
Google Scholar
PubMed Close

adverse outcome of pregnancy is less common than the early pregnancy loss but frequent enough to be of major concern [ 1 ]. Hyperthyroidism in women of reproductive age is most often caused by Graves' disease with autoimmunity against the thyroid

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000365101
Volume/Issue:
Volume 3: Issue 3
Free access
Giorgio Radetti Marienklinik, Bolzano, Italy

Search for other papers by Giorgio Radetti in
Google Scholar
PubMed Close
,
Franco Rigon Department of Paediatrics, University of Padua, Padua, Italy

Search for other papers by Franco Rigon in
Google Scholar
PubMed Close
,
Alessandro Salvatoni Department of Medicine and Surgery, University of Insubria, Varese, Italy

Search for other papers by Alessandro Salvatoni in
Google Scholar
PubMed Close
,
Irene Campi Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, IRCCS, Milan, Italy

Search for other papers by Irene Campi in
Google Scholar
PubMed Close
,
Tiziana De Filippis Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, IRCCS, Milan, Italy

Search for other papers by Tiziana De Filippis in
Google Scholar
PubMed Close
,
Valentina Cirello Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, IRCCS, Milan, Italy

Search for other papers by Valentina Cirello in
Google Scholar
PubMed Close
,
Silvia Longhi Department of Paediatrics, Regional Hospital of Bolzano, Bolzano, Italy

Search for other papers by Silvia Longhi in
Google Scholar
PubMed Close
,
Fabiana Guizzardi Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, IRCCS, Milan, Italy

Search for other papers by Fabiana Guizzardi in
Google Scholar
PubMed Close
,
Marco Bonomi Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy

Search for other papers by Marco Bonomi in
Google Scholar
PubMed Close
, and
Luca Persani Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy

Search for other papers by Luca Persani in
Google Scholar
PubMed Close

significant changes in tissue sensitivity to THs. Differently from RETH patients, who display hyperthyroid symptoms with increasing LT4 dose, our patients were euthyroid even in the presence of high FT4 levels with a normal TSH, similarly to what reported in

Article Type:
Research Article
Collections:
Thyroid hormone action
DOI:
https://doi.org/10.1530/ETJ-21-0054
Volume/Issue:
Volume 11: Issue 2
Open access
Katarzyna Pelewicz Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland

Search for other papers by Katarzyna Pelewicz in
Google Scholar
PubMed Close
,
Rafał Wolny Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland

Search for other papers by Rafał Wolny in
Google Scholar
PubMed Close
,
Tomasz Bednarczuk Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland

Search for other papers by Tomasz Bednarczuk in
Google Scholar
PubMed Close
, and
Piotr Miśkiewicz Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland

Search for other papers by Piotr Miśkiewicz in
Google Scholar
PubMed Close

it can persist causing hypothyroidism. A pathologic response to the exogenous iodine load may lead to iodine-induced hyperthyroidism (IIH), known as the Jod-Basedow phenomenon. IIH is infrequent, but elderly patients and individuals with autonomously

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000515126
Volume/Issue:
Volume 10: Issue 4
Free access
Allan Carlé Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Department of Clinical Institute, Aalborg University, Aalborg, Denmark

Search for other papers by Allan Carlé in
Google Scholar
PubMed Close
,
Nils Knudsen Department of Endocrinology I, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Nils Knudsen in
Google Scholar
PubMed Close
,
Torben Jørgensen Centre for Clinical Research and Prevention, Capital Region of Denmark, Copenhagen, Denmark
Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Torben Jørgensen in
Google Scholar
PubMed Close
,
Bettina Thuesen Centre for Clinical Research and Prevention, Capital Region of Denmark, Copenhagen, Denmark

Search for other papers by Bettina Thuesen in
Google Scholar
PubMed Close
,
Jesper Karmisholt Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Department of Clinical Institute, Aalborg University, Aalborg, Denmark

Search for other papers by Jesper Karmisholt in
Google Scholar
PubMed Close
,
Stine Linding Andersen Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed Close
, and
Inge Bülow Pedersen Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Department of Clinical Institute, Aalborg University, Aalborg, Denmark

Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed Close

Introduction Hyperthyroidism is a common disease affecting women more often than men [ 1 ]. As first described by Parker et al. in 1961 [ 2 ], pregnancy is accompanied by a fall in thyroid antibody concentrations. Most [ 3 , 4 ], but not all

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000494836
Volume/Issue:
Volume 8: Issue 2
Free access
Caiyan Mo Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Search for other papers by Caiyan Mo in
Google Scholar
PubMed Close
,
Han Chen Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Search for other papers by Han Chen in
Google Scholar
PubMed Close
,
Qi Zhang Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Search for other papers by Qi Zhang in
Google Scholar
PubMed Close
,
Ying Guo Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Search for other papers by Ying Guo in
Google Scholar
PubMed Close
, and
Liyong Zhong Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Search for other papers by Liyong Zhong in
Google Scholar
PubMed Close

Introduction Graves' disease (GD) is an autoimmune disease of the thyroid gland and is the most common cause of hyperthyroidism. The annual incidence is 20–50 cases per 100,000 people, with a peak incidence between the ages of 30 and 50. The

Article Type:
Review Article
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-22-0223
Volume/Issue:
Volume 12: Issue 4
Open access